Annual EBITDA
$2.61B$346.11M+15.27%
Summary
- Current Value
- As of today, UHS annual EBITDA is $2.61B, up +15.27% on
- Historical Performance
- UHS annual EBITDA is up +59.03% over the past 3 years, up +39.91% over the past 5 years
- All-Time High Comparison
- UHS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- UHS annual EBITDA is +59.03% above its 3-year low of $1.64B reached on an earlier date
- Sector Comparison
- UHS annual EBITDA is higher than 95.90% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.61B | +15.3% | +59.0% | +39.9% | +234.2% | |
| Quarterly EBITDA | $684.01M | +4.9% | +61.4% | +19.4% | +124.0% | |
| TTM EBITDA | $2.70B | +12.1% | +61.1% | +33.4% | +158.2% | |
| Price | $159.31 | -2.2% | +14.8% | +0.2% | +220.9% | |
| PE Ratio | 6.49 | -24.4% | -55.0% | -48.4% | -59.0% | |
| Annual Revenue | $17.36B | +9.7% | +29.6% | +50.2% | +211.9% | |
| Annual EPS | $23.10 | +37.3% | +152.7% | +109.4% | +887.0% | |
| $1.99B | +18.6% | +87.9% | +46.9% | +257.4% | ||
| Annual Net Income | $1.51B | +29.9% | +130.3% | +59.1% | +449.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.61B | at high | |
| 5Y | $2.61B | at high | |
| All | $2.61B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.64B | N/A | +59.0% |
| 5Y | $1.64B | +59.0% | |
| All | $16.54M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of UHS?
As of today, UHS annual EBITDA is $2.61B
What is 1-year change in UHS annual EBITDA?
UHS annual EBITDA is up +15.27% year-over-year
What is 3-year change in UHS annual EBITDA?
UHS annual EBITDA is up +59.03% over the past 3 years
How far is UHS annual EBITDA from its all-time high?
UHS annual EBITDA is currently at its all-time high
How does UHS annual EBITDA rank versus sector peers?
UHS annual EBITDA is higher than 95.90% of companies in Healthcare sector
When is UHS next annual earnings release?
As of today, the next annual earnings release for UHS has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$684.01M$25.73M+3.91%
Summary
- Current Value
- As of today, UHS quarterly EBITDA is $684.01M, up +3.91% on
- Historical Performance
- UHS quarterly EBITDA is up +4.87% year-over-year, up +61.37% over the past 3 years
- All-Time High Comparison
- UHS quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- UHS quarterly EBITDA is +61.88% above its 3-year low of $422.55M reached on
- Sector Comparison
- UHS quarterly EBITDA is higher than 96.06% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $684.01M | +3.9% | +4.9% | +61.4% | +19.4% | |
| Annual EBITDA | $2.61B | – | +15.3% | +59.0% | +39.9% | |
| TTM EBITDA | $2.70B | +1.2% | +12.1% | +61.1% | +33.4% | |
| Price | $159.31 | -5.2% | -2.2% | +14.8% | +0.2% | |
| PE Ratio | 6.49 | -7.3% | -24.4% | -55.0% | -48.4% | |
| Quarterly Revenue | $4.64B | +3.2% | +8.3% | +30.7% | +45.0% | |
| Quarterly EPS | $5.98 | +5.8% | +10.0% | +147.4% | +57.9% | |
| $516.68M | +2.8% | +3.3% | +84.4% | +17.7% | ||
| Quarterly Net Income | $364.59M | +1.6% | +0.6% | +115.4% | +12.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $684.01M | at high | |
| 3Y | $684.01M | at high | |
| 5Y | $684.01M | at high | |
| All | $684.01M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $652.27M | N/A | +4.9% |
| 3Y | $422.55M | +61.9% | |
| 5Y | $376.64M | +81.6% | |
| All | -$424.40M | +261.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of UHS?
As of today, UHS quarterly EBITDA is $684.01M
What is UHS quarterly EBITDA most recent change?
UHS quarterly EBITDA was up +3.91% on June 30, 2026
What is 1-year change in UHS quarterly EBITDA?
UHS quarterly EBITDA is up +4.87% year-over-year
How far is UHS quarterly EBITDA from its all-time high?
UHS quarterly EBITDA is currently at its all-time high
How does UHS quarterly EBITDA rank versus sector peers?
UHS quarterly EBITDA is higher than 96.06% of companies in Healthcare sector
When is UHS next earnings release?
The next earnings release for UHS is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$2.70B$31.74M+1.19%
Summary
- Current Value
- As of today, UHS TTM EBITDA is $2.70B, up +1.19% on
- Historical Performance
- UHS TTM EBITDA is up +12.09% year-over-year, up +61.11% over the past 3 years
- All-Time High Comparison
- UHS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- UHS TTM EBITDA is +61.11% above its 3-year low of $1.68B reached on an earlier date
- Sector Comparison
- UHS TTM EBITDA is higher than 95.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.70B | +1.2% | +12.1% | +61.1% | +33.4% | |
| Annual EBITDA | $2.61B | – | +15.3% | +59.0% | +39.9% | |
| Quarterly EBITDA | $684.01M | +3.9% | +4.9% | +61.4% | +19.4% | |
| Price | $159.31 | -5.2% | -2.2% | +14.8% | +0.2% | |
| PE Ratio | 6.49 | -7.3% | -24.4% | -55.0% | -48.4% | |
| TTM Revenue | $18.11B | +2.0% | +10.1% | +31.3% | +48.4% | |
| TTM EPS | $24.55 | +2.3% | +29.3% | +155.0% | +94.3% | |
| $2.06B | +0.8% | +13.6% | +87.8% | +37.4% | ||
| TTM Net Income | $1.55B | +0.1% | +20.4% | +128.5% | +43.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.70B | at high | |
| 3Y | $2.70B | at high | |
| 5Y | $2.70B | at high | |
| All | $2.70B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.41B | N/A | +12.1% |
| 3Y | $1.68B | N/A | +61.1% |
| 5Y | $1.59B | +70.3% | |
| All | -$197.00M | +1470.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of UHS?
As of today, UHS TTM EBITDA is $2.70B
What is UHS TTM EBITDA most recent change?
UHS TTM EBITDA was up +1.19% on June 30, 2026
What is 1-year change in UHS TTM EBITDA?
UHS TTM EBITDA is up +12.09% year-over-year
How far is UHS TTM EBITDA from its all-time high?
UHS TTM EBITDA is currently at its all-time high
How does UHS TTM EBITDA rank versus sector peers?
UHS TTM EBITDA is higher than 95.87% of companies in Healthcare sector
When is UHS next earnings release?
The next earnings release for UHS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- UHS Official Website uhs.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/352915/000119312526071676/0001193125-26-071676-index.htm
- UHS Profile on Yahoo Finance finance.yahoo.com/quote/UHS
- UHS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/uhs